Register your email address to show your organization how much you value your AdisInsight subscription.
With your consent we’ll provide this information to your organization’s account administrator to aid in the renewal decision and we will send you important updates about AdisInsight.
Please refer to our
privacy policy
for information on how we protect your personal information.
Enter e-mail address here
Enter valid e-mail address
You will receive an email to validate your email address.
You will see this pop-up again if your browser cookies are cleared on your computer.
A phase II clinical trial of BH011 injection for the treatment of untreated or chemotherapy-relapsed intermediate- and high-risk non-muscle-invasive bladder cancer
A phase II clinical trial of BH011 injection for the treatment of untreated or chemotherapy-relapsed intermediate- and high-risk non-muscle-invasive bladder cancer
Status:Planning
Phase of Trial:
Phase II
Latest Information Update:21 Jun 2022
Price :
$35
*
Note:
Adis is an information provider.
Final gross price and currency may vary according to local VAT and billing address.
Your purchase entitles you to full access to the information contained in our trial profile at the time of purchase.
A link to download a PDF version of the trial profile will be included in your email receipt.